{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P22303",
      "entity_text" : "AChE",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:5353894",
      "entity_text" : "pralidoxime",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The mainstay of treatment involves atropine, a central and peripheral muscarinic receptor antagonist, and pralidoxime chloride, which reactivates inhibited AChE [XREF_BIBR].",
  "reading_complete" : "2020-08-04T12:28:20Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T12:26:16Z",
  "trigger" : "inhibited",
  "evidence" : [ "pralidoxime chloride, which reactivates inhibited AChE" ],
  "pmc_id" : "2996541",
  "score" : 0
}